Up to 100 g of Intravenous Vitamin C Appears to be Safe and Elicits No Adverse Effects but Needs Further Evaluation in High-Risk Groups Patrick M. HonoreSydney BlackmanRachid Attou Commentary 30 July 2022 Pages: 1199 - 1202
Pharmacological Basis for Abrogating Myocardial Reperfusion Injury Through a Multi-Target Combined Antioxidant Therapy Daniel San-Martín-MartínezDayanara Serrano-LemusRamón Rodrigo Review Article 25 July 2022 Pages: 1203 - 1218
Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy Maor WanounouYoseph CaracoEmilio Perucca Review Article 27 July 2022 Pages: 1219 - 1236
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study Ping ChenGreg ReedQi Chen Original Research Article Open access 25 June 2022 Pages: 1237 - 1249
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models Mattia BertonSara BettonteCatia Marzolini Original Research Article Open access 14 June 2022 Pages: 1251 - 1270
First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties Junichiro James KazamaFumihiko KoiwaTadao Akizawa Original Research Article Open access 28 June 2022 Pages: 1271 - 1284
Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome Willem Jan R. FokkinkSander J. van TilburgBart C. Jacobs Original Research Article Open access 04 July 2022 Pages: 1285 - 1296
Quantitative Prediction of Drug Interactions Caused by Cytochrome P450 2B6 Inhibition or Induction Veronica Di PaoloFrancesco Maria FerrariLuigi Quintieri Original Research Article 20 July 2022 Pages: 1297 - 1306
Allopregnanolone Concentrations in Breast Milk and Plasma from Healthy Volunteers Receiving Brexanolone Injection, With Population Pharmacokinetic Modeling of Potential Relative Infant Dose Jeffrey WaldAnja HenningssonKristina M. Deligiannidis Original Research Article Open access 23 July 2022 Pages: 1307 - 1319
Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients? Robert MarcecRobert Likic Research Letter 23 July 2022 Pages: 1321 - 1323
Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients Eveline WallenburgRob ter HeineRoger J. M. Brüggemann Correction Open access 10 August 2022 Pages: 1325 - 1329